Poseida Therapeutics, Inc.

Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac? DNA Delivery System, Cas-CLOVER? Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. The Company has formed strategic collaborations with Roche and Astellas to unlock the promise of cell therapies for cancer patients. Learn more at www.poseida.com.

网站

https://poseida.com/

Poseida Therapeutics, Inc.的外部链接

所属行业

生物技术研究

规模

201-500 人

总部

San Diego，California

类型

上市公司

创立

2014

领域

Genome Engineering、CAR-T cells、Gene Therapy、Gene Editing、Cell Therapy、Adoptive Cell Therapy、Multiple Myeloma、Prostate Cancer、Transposon、Non-viral、Biotechnology、Immunotherapy、Regenerative Medicine、T-cells、Allogeneic、Oncology、Immuno-oncology、Immunology、Poseida、Cytotoxic T Lymphocytes、piggyBac?、piggyBac? DNA Modification System、Cas-CLOVER?和TAL-CLOVER?